Msa Gujarat Molecular Imaging (India) Private Limited

Msa Gujarat Molecular Imaging (India) Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2011PTC218557 Incorporated 13 June 2011 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹21.07 Cr
▲ 22% YoY
Net profit · FY 2025
₹7.79 Cr
Net margin 37%
EBITDA · FY 2025
₹12.18 Cr
EBITDA margin 57.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.05 Lakh
Issued & subscribed
Satisfied charges
₹7.55 Cr
No open charges
Company age
15 yrs
Est. 2011
Directors on board
5
As per MCA filings

About Msa Gujarat Molecular Imaging (India) Private Limited

Data last updated:

Msa Gujarat Molecular Imaging (India) Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 June 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2011PTC218557. Its GSTIN is 24AAHCM2892C1ZL (Gujarat).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.05 Lakh. It is led by directors including Nilesh Ramanbhai Patel (Managing Director) and Gaurav Patel (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹21.07 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹7.79 Cr (net margin 37%) and EBITDA of ₹12.18 Cr (EBITDA margin 57.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 30% over five years.

As per MCA filings, the company has satisfied charges of ₹7.55 Cr on record.

Msa Gujarat Molecular Imaging (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0025622). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999MH2011PTC218557
Registration Number 218557
Incorporation Date 13 June 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-24-0025622

Recognitions & Rankings of Msa Gujarat Molecular Imaging (India)

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-24-0025622

Contact details

Msa Gujarat Molecular Imaging (India) Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. Me IV 701 Marathon Era IV, Ganpat Rao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Msa Gujarat Molecular Imaging (India) Private Limited, buy the company report.

Comprehensive company report
Msa Gujarat Molecular Imaging (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Msa Gujarat Molecular Imaging (India) is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC13Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities

To see the full business activity and turnover split of Msa Gujarat Molecular Imaging (India) Private Limited, buy the company report.

Financials of Msa Gujarat Molecular Imaging (India) Private Limited

FY 2025 filings available

Msa Gujarat Molecular Imaging (India) Private Limited reported revenue of ₹21.07 Cr (up 22% YoY) for FY 2025.

Revenue · FY 2025
₹21.07 Cr ▲ 22%
Net profit · FY 2025
₹7.79 Cr margin 37%
EBITDA · FY 2025
₹12.18 Cr margin 57.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 29%
5 years · compounded
▲ 30%
EBITDA CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 46%
5 years · compounded
▲ 40%

Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 22% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹21.07 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹12.18 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹7.79 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin57.8%
Net Profit Margin37%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Msa Gujarat Molecular Imaging (India) Private Limited, buy the company report.

Board of directors of Msa Gujarat Molecular Imaging (India) Private Limited

Msa Gujarat Molecular Imaging (India) has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nilesh Ramanbhai PatelManaging Director20 Jan 201511 Years 9 MonthsCurrent
Jitendra Dahyabhai RayDirector04 Sep 201511 Years 2 MonthsCurrent
Manas MayankDirector17 Sep 20188 Years 2 MonthsCurrent
Gaurav PatelWhole-Time Director18 Jun 20251 Years 5 MonthsCurrent
Yeshaben PatelWhole-Time Director18 Jun 20251 Years 5 MonthsCurrent

Auditor

Msa Gujarat Molecular Imaging (India) Private Limited is audited by PARIKH SHAH CHOTALIA & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
PARIKH SHAH CHOTALIA & ASSOCIATESFY 2022118493W

Shareholding

The shareholding of Msa Gujarat Molecular Imaging (India) Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Msa Gujarat Molecular Imaging (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹7.55 Cr
Breakdown by lending institutions
Yes Bank Limited₹7.11 Cr
Hdfc Bank Limited₹0.44 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Jul 2022100873776Hdfc Bank Limited₹18.24 LakhSatisfied
03 Jan 2022100541004Hdfc Bank Limited₹5.22 LakhSatisfied
09 Dec 2021100539238Hdfc Bank Limited₹6.92 LakhSatisfied
23 Oct 2020100387546Hdfc Bank Limited₹14.09 LakhSatisfied
16 Oct 2020100382215Yes Bank Limited₹96.08 LakhSatisfied

To see the full charge records of Msa Gujarat Molecular Imaging (India) Private Limited, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Msa Gujarat Molecular Imaging (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Msa Gujarat Molecular Imaging (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAHCM2892C1ZLGujaratActive15 Dec 2017

To see the full GST registrations and return filing status of Msa Gujarat Molecular Imaging (India) Private Limited, buy the company report.

Recent activity

Msa Gujarat Molecular Imaging (India) Private Limited has 11 board changes on record since 2015: 5 appointments and 6 cessations. The latest: Gaurav Patel was appointed as Whole-Time Director on 18 Jun 2025.

AGM
Msa Gujarat Molecular Imaging (India) Private Limited last Annual general meeting of members was held on 29 Dec 2025 as per latest MCA records.
Charges
A charge registered on 11 Jul 2022 via Charge ID 100873776 with Hdfc Bank Limited was fully satisfied on 25 Aug 2025.
Charges
A charge registered on 03 Jan 2022 via Charge ID 100541004 with Hdfc Bank Limited was fully satisfied on 25 Aug 2025.
Charges
A charge registered on 09 Dec 2021 via Charge ID 100539238 with Hdfc Bank Limited was fully satisfied on 25 Aug 2025.
Charges
A charge registered on 23 Oct 2020 via Charge ID 100387546 with Hdfc Bank Limited was fully satisfied on 25 Aug 2025.
Charges
A charge registered on 16 Oct 2020 via Charge ID 100382215 with Yes Bank Limited was fully satisfied on 13 Aug 2025.
Charges
A charge registered on 07 Dec 2019 via Charge ID 100310421 with Yes Bank Limited was fully satisfied on 13 Aug 2025.
Charges
A charge registered on 07 Dec 2019 via Charge ID 100310445 with Yes Bank Limited was fully satisfied on 13 Aug 2025.
Appointed
Gaurav Patel was appointed as Whole-Time Director.
Appointed
Yeshaben Patel was appointed as Whole-Time Director.
Filing
Msa Gujarat Molecular Imaging (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.24 Lakh with Charge ID 100873776 was registered on 11 Jul 2022.

16 earlier events are in the company report.

Frequently asked questions

Msa Gujarat Molecular Imaging (India) is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 June 2011 (15+ years old) and is registered under CIN U74999MH2011PTC218557.

Msa Gujarat Molecular Imaging (India) has 5 current directors:

The latest financial statements of Msa Gujarat Molecular Imaging (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 December 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Msa Gujarat Molecular Imaging (India) is 24AAHCM2892C1ZL, registered in Gujarat.

The CIN (Corporate Identification Number) of Msa Gujarat Molecular Imaging (India) is U74999MH2011PTC218557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Msa Gujarat Molecular Imaging (India) was incorporated on 13 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Gaurav Patel was appointed as Whole-Time Director on 18 Jun 2025. Yeshaben Patel was appointed as Whole-Time Director on 18 Jun 2025. Manas Mayank ceased to be Additional Director on 30 Sep 2019. Msa Gujarat Molecular Imaging (India) has 11 board changes on record in total.

Yes, Msa Gujarat Molecular Imaging (India) is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-24-0025622).

The registered office of Msa Gujarat Molecular Imaging (India) is at Flat No. Me IV 701 Marathon Era IV, Ganpat Rao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.

Msa Gujarat Molecular Imaging (India) operates in the pharma industry, in the drug formulation and development segment.